Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behcet's disease

Journal of Rheumatology

Volumn 24, Issue 7, 1997, Pages 1332-1336

  Carletto, Antonio ^a,b,e   Pacor, Maria Luisa ^a,c   Biasi, Domenico ^a,b   Caramaschi, Paola ^a,c   Zeminian, Stefano ^a,c   Bellavite, Paolo ^a,d   Bambara, Lisa Maria ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b Institute of Patologia Medica   (Italy)

^c Institute of Clinica Medica   (Italy)

^d Inst of Clin and Microscopia Clin

^e POLICLINICO BORGO ROMA   (Italy)

Author keywords

Behcet's disease; Chemotaxis; In vivo neutrophil migration; Neutrophil adhesion; Skin inflammation; Superoxide production

Indexed keywords

AEROBIC METABOLISM; ARTICLE; BEHCET DISEASE; CORRELATION FUNCTION; FEMALE; GENITAL ULCER; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; UVEITIS;

ADULT; BEHCET SYNDROME; CARCINOGENS; CELL ADHESION; CELL MOVEMENT; FEMALE; HUMANS; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; SKIN; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; ZYMOSAN;

EID: 0030809474     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chajek T, Fainaru M: Behçet's disease. Reports of 41 cases and review of the literature. Medicine 1975;54:179-96.
2. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
3. Djawari D, Hornstein OP, Schotz J: Enhancement of granulocyte chemotaxis in Behçet's disease. Arch Dermatol Res 1981;270:81-8.
4. Efthimiou J, Addison IE, Johnsonn BU: In vivo leukocyte migration in Behçet's syndrome. Ann Rheum Dis 1989;49:206-10.
5. Jorizzo JL, Hudson RD, Schalmstieg FC, et al: Behçet's syndrome: Immune regulation, circulating immune complex, neutrophils migration and colchicine therapy. J Am Acad Dermatol 1984;10:205-14.
6. Takeuki A, Kobayashi K, Mori M, et al: The mechanism of hyperchemotaxis in Behçet's disease. J Rheumatol 1981;8:40-4.
7. Matsumura N, Mizushima Y: Leukocyte movement and colchicine treatment in Behçet's disease (letter). Lancet 1975;2:813.
8. Takeno M, Karidone A, Yamashita N, et al: Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426-33.
9. Mege JL, Dilsen N, Sanguedolce V, et al: Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544-9.
10. Pronai L, Ichikawa Y, Nakazawa H, et al: Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet's disease - effect of colchicine. Clin Exp Rheumatol 1991;9:227-33.
11. Ozgun S, Akoglu T, Direskeneli H, Yurdakull S: PMN adhesion to endothelial cells in patients with Behçet's disease (abstr). Rev Med Int 1993;(suppl 1)14:133S.
12. Inaba G, Kaku HH, Ujihara H, et al: Leukocyte adhesion molecules in active ocular lesions of Behçet's disease (abstr). Rev Med Int 1993;(suppl 1)14:24S.
13. Metcalf JA, Gallin JI, Nauseef WM, Root RK: Laboratory manual of neutrophil function. New York: Raven Press, 1986.
14. Senn HJ, Jungi WF: Neutrophil migration in health and disease. Semin Hematol 1975;12:27-45.
15. Biasi D, Bambara LM, Carletto A, et al: Factor-specific changes in oxidative burst response of human neutrophils in skin window exudates. Inflammation 1993;17:13-23.
16. Biasi D, Carletto A, Caramaschi P, et al: Neutrophil functions, spondylarthropathies and HLA-B27: A study of 43 patients. Clin Exp Rheumatol 1995;13:623-7.
17. Babior BM, Kipnes RS, Curnutte JT: Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973;52:741-4.
18. Bellavite P, Chirumbolo S, Mansoldo C, Gandini G, Dri P: A simultaneous assay for oxidative metabolism and adhesion of human neutrophils. Evidence for correlations and dissociation of the two responses. J Leukocyte Biol 1992;51:329-33.
19. Djawari D, Hornstein OP, Lukner L: Skin window examination according to Rebuk and cutaneous pathergy test in patients with Behçet's disease. Dermatol 1985;170:265-70.
20. Mizushima Y: Recent research into Behçet's disease in Japan. Int J Tiss React 1988;10:59-65.
21. Haim S, Sobel JD, Friedmann-Birnbaum R, et al: Histological and direct immunofluorescence study of cutaneous hyperactivity in Behçet's disease. Br J Dermatol 1976;95:631-6.
22. Jorizzo JL, Solomon AR, Zanolli MD, et al: Neutrophilic vascular reactions. J Am Acad Dermatol 1988;19:983-1005.
23. Niwa Y, Miyake S, Sakane T, et al: Autooxidative damage in Behçet's disease - endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982;49:247-55.
24. Fujita Y, Yamada MM, Asai K, et al: Generation of superoxide radical by PMN in Behçet's disease. Jpn J Ophthalmol 1984;3:221-6.
25. Sobel JD, Haim S, Obedeanu N, Meshulam T: Polymorphonuclear leukocyte function in Behçet's disease. J Clin Pathol 1977;30:250-3.
26. Biasi D, Bambara LM, Carletto A, et al: Molecular mechanisms of priming: Exudate human neutrophils are primed to fMET-LEU-PHE but have normal intracellular calcium and cAMP responses. Bull Mol Biol Med 1993;18:225-35.
27. Biasi D, Carletto A, Dell'Agnola C, et al: Neutrophil migration, oxidative metabolism and adhesion in young and elderly subjects. Inflammation 1996;20:673-81.
28. Tortorella C, Ottolenghi A, Pugliese P, Jirillo E, Antonaci S: Polymorphonuclear cells in elderly subjects. Facts Res Gerontol 1994;3:211-20.
29. Briheim G, Stendhal O, Coble BI, Dahlgren C: Exudate polymorphonuclear leukocytes isolated from chambers are primed for enhanced response to subsequent stimulation with the chemoattractant fMet-Leu-Phe and C3 opsonized yeast particles. Inflammation 1988;12:141-52.
30. Van Epps DE, Garcia ML: Enhancement of neutrophil function as a result of prior exposure to chemotactic factor. J Clin Invest 1980;66:167-75.
31. Bellavite P, Carletto A, Biasi D, et al: Studies of skin window exudate human neutrophils. Complex patterns of adherence to serum-coated surfaces in dependence on fMLP doses. Inflammation 1994;18:575-87.
32. Paty PB, Graeff RW, Mates SJ, Hunt TK: Superoxide production by wound neutrophils. Evidence for increased activity of the NADPH oxidase. Arch Surg 1990;125:65-9.
33. Nurcombe HL, Bucknall RC, Edwards SW: Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: Priming and action in vivo. Ann Rheum Dis 1991;50:147-53.